164 related articles for article (PubMed ID: 32168858)
1. BEL β-Trefoil Reduces the Migration Ability of RUNX2 Expressing Melanoma Cells in Xenotransplanted Zebrafish.
Valenti MT; Marchetto G; Perduca M; Tiso N; Mottes M; Dalle Carbonare L
Molecules; 2020 Mar; 25(6):. PubMed ID: 32168858
[TBL] [Abstract][Full Text] [Related]
2. Runx2 downregulation, migration and proliferation inhibition in melanoma cells treated with BEL β-trefoil.
Perduca M; Dalle Carbonare L; Bovi M; Innamorati G; Cheri S; Cavallini C; Scupoli MT; Mori A; Valenti MT
Oncol Rep; 2017 Apr; 37(4):2209-2214. PubMed ID: 28350114
[TBL] [Abstract][Full Text] [Related]
3. RUNX2 is overexpressed in melanoma cells and mediates their migration and invasion.
Boregowda RK; Olabisi OO; Abushahba W; Jeong BS; Haenssen KK; Chen W; Chekmareva M; Lasfar A; Foran DJ; Goydos JS; Cohen-Solal KA
Cancer Lett; 2014 Jun; 348(1-2):61-70. PubMed ID: 24657655
[TBL] [Abstract][Full Text] [Related]
4. BEL β-trefoil: a novel lectin with antineoplastic properties in king bolete (Boletus edulis) mushrooms.
Bovi M; Cenci L; Perduca M; Capaldi S; Carrizo ME; Civiero L; Chiarelli LR; Galliano M; Monaco HL
Glycobiology; 2013 May; 23(5):578-92. PubMed ID: 23213111
[TBL] [Abstract][Full Text] [Related]
5. Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model.
Precazzini F; Pancher M; Gatto P; Tushe A; Adami V; Anelli V; Mione MC
Dev Biol; 2020 Jan; 457(2):215-225. PubMed ID: 30998907
[TBL] [Abstract][Full Text] [Related]
6. Lysosomal Zn
Du W; Gu M; Hu M; Pinchi P; Chen W; Ryan M; Nold T; Bannaga A; Xu H
Cell Rep; 2021 Oct; 37(3):109848. PubMed ID: 34686351
[TBL] [Abstract][Full Text] [Related]
7. Runx2 stimulates neoangiogenesis through the Runt domain in melanoma.
Cecconi D; Brandi J; Manfredi M; Serena M; Dalle Carbonare L; Deiana M; Cheri S; Parolini F; Gandini A; Marchetto G; Innamorati G; Avanzi F; Antoniazzi F; Marengo E; Tiso N; Mottes M; Zipeto D; Valenti MT
Sci Rep; 2019 May; 9(1):8052. PubMed ID: 31142788
[TBL] [Abstract][Full Text] [Related]
8. Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures.
Curiel-Olmo S; García-Castaño A; Vidal R; Pisonero H; Varela I; León-Castillo A; Trillo E; González-Vela C; García-Diaz N; Almaraz C; Moreno T; Cereceda L; Madureira R; Martinez N; Ortiz-Romero P; Valdizán E; Piris MA; Vaqué JP
Oncotarget; 2015 Sep; 6(28):25452-65. PubMed ID: 26327537
[TBL] [Abstract][Full Text] [Related]
9. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
[TBL] [Abstract][Full Text] [Related]
10. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
[TBL] [Abstract][Full Text] [Related]
11. Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma.
Bianchini F; Portioli E; Ferlenghi F; Vacondio F; Andreucci E; Biagioni A; Ruzzolini J; Peppicelli S; Lulli M; Calorini L; Battistini L; Zanardi F; Sartori A
Cancer Lett; 2019 Apr; 446():25-37. PubMed ID: 30639534
[TBL] [Abstract][Full Text] [Related]
12. A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.
Stueven NA; Schlaeger NM; Monte AP; Hwang SL; Huang CC
Toxicol Appl Pharmacol; 2017 Dec; 337():30-38. PubMed ID: 29042215
[TBL] [Abstract][Full Text] [Related]
13. Transient receptor potential cation 3 channel regulates melanoma proliferation and migration.
Oda K; Umemura M; Nakakaji R; Tanaka R; Sato I; Nagasako A; Oyamada C; Baljinnyam E; Katsumata M; Xie LH; Narikawa M; Yamaguchi Y; Akimoto T; Ohtake M; Fujita T; Yokoyama U; Iwatsubo K; Aihara M; Ishikawa Y
J Physiol Sci; 2017 Jul; 67(4):497-505. PubMed ID: 27613608
[TBL] [Abstract][Full Text] [Related]
14. Identification of a small molecule that downregulates MITF expression and mediates antimelanoma activity in vitro.
Cheng C; Yang HW; Shang JF; Li WW; Sun QZ; Chen X; Cao ZX; Yao SH; Yang SY
Melanoma Res; 2016 Apr; 26(2):117-24. PubMed ID: 26684062
[TBL] [Abstract][Full Text] [Related]
15. Exploiting Honokiol-induced ER stress CHOP activation inhibits the growth and metastasis of melanoma by suppressing the MITF and β-catenin pathways.
Chiu CS; Tsai CH; Hsieh MS; Tsai SC; Jan YJ; Lin WY; Lai DW; Wu SM; Hsing HY; Arbiser JL; Sheu ML
Cancer Lett; 2019 Feb; 442():113-125. PubMed ID: 30391358
[TBL] [Abstract][Full Text] [Related]
16. UV radiation promotes melanoma dissemination mediated by the sequential reaction axis of cathepsins-TGF-β1-FAP-α.
Wäster P; Orfanidis K; Eriksson I; Rosdahl I; Seifert O; Öllinger K
Br J Cancer; 2017 Aug; 117(4):535-544. PubMed ID: 28697174
[TBL] [Abstract][Full Text] [Related]
17. Gene expression analyses of primary melanomas reveal CTHRC1 as an important player in melanoma progression.
Eriksson J; Le Joncour V; Nummela P; Jahkola T; Virolainen S; Laakkonen P; Saksela O; Hölttä E
Oncotarget; 2016 Mar; 7(12):15065-92. PubMed ID: 26918341
[TBL] [Abstract][Full Text] [Related]
18. Melanoma cell growth inhibition by betagamma-CAT, which is a novel non-lens betagamma-crystallin and trefoil factor complex from frog Bombina maxima skin.
He YY; Liu SB; Lee WH; Zhang Y
Toxicon; 2008 Aug; 52(2):341-7. PubMed ID: 18625262
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological Inhibition of Myocardin-related Transcription Factor Pathway Blocks Lung Metastases of RhoC-Overexpressing Melanoma.
Haak AJ; Appleton KM; Lisabeth EM; Misek SA; Ji Y; Wade SM; Bell JL; Rockwell CE; Airik M; Krook MA; Larsen SD; Verhaegen M; Lawlor ER; Neubig RR
Mol Cancer Ther; 2017 Jan; 16(1):193-204. PubMed ID: 27837031
[TBL] [Abstract][Full Text] [Related]
20. High LIFr expression stimulates melanoma cell migration and is associated with unfavorable prognosis in melanoma.
Guo H; Cheng Y; Martinka M; McElwee K
Oncotarget; 2015 Sep; 6(28):25484-98. PubMed ID: 26329521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
